obesity drug news today glp-1 october 27 2025 Weight-Loss Demonstration Begins July 2026 GLP-1 Pipeline Update: November 2025
Description
July 2024 On July 14, 2024, the Hon
The need to inject the drug every week, however, can be a deterrent for the needle-phobic
Patients currently on semaglutide who have hit a weight loss plateau often see renewed progress when transitioning to tirzepatide, likely due to the additional GIP receptor activation
What to do : These symptoms are usually mild and go away on their own
Acute pancreatitis
Weight loss can also occasionally trigger gout flares (as noted in NICE NG219), which may present as acute joint pain, particularly in a single joint
